Cambridge, United States
InVivo Therapeutics is a biotechnology and healthcare company focused on treating spinal cord injuries. Founded in 2005 with technology co-invented by Robert Langer and Joseph P. Vacanti, the company has received notable recognition, including the David S. Apple Award in 2011 and the 2015 Becker’s Healthcare Spine Device Award. Headquartered in Cambridge, MA, the publicly-traded company's Neuro-Spinal Scaffold, intended to support appositional healing in spinal cord injuries, has received a Humanitarian Use Device (HUD) designation and is currently undergoing evaluation in the INSPIRE pivotal probable benefit study.
The company recently received a $9.00M Post-IPO Equity investment in October 7, 2022. Despite not disclosing the investor, the company's pioneering technology and potential to address a critical medical need make it an intriguing investment opportunity in the biotechnology and healthcare sector.
